Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Triple Negative Breast Neoplasms 1 Solid Tumor 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms 1 Mesothelioma, Malignant 1 Mesothelioma 1 Kidney Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Fluorodeoxyglucose F18 3 Blood Specimen Collection 2 trifluridine tipiracil drug combination 1 tegafur-gimeracil-oteracil 1 Tegafur 1 Surveys and Questionnaires 1 Specimen Handling 1 S 1 (combination) 1 Radiomics 1 Proton Therapy 1 Postmortem Imaging 1 PMEPA1 protein, human 1 Off-Label Use 1 Latent Class Analysis 1 Immunohistochemistry 1 Histocompatibility Testing 1 Hepatitis B Vaccines 1 Fluorouracil 1 Capecitabine 1 Blood Component Removal 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Solid Tumor × Blood Component Removal × Clear all

NCT07137312 2025-12-23

Ex Vivo Expansion (ACT-X)

Mayo Clinic

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡